In human breast cancer cells, SET KD has been shown to decrease c-Myc protein levels by enhancing the dephosphorylation of c-Myc Ser6216, while in this study SET KD did not alter c-Myc protein levels in canine mammary tumor cells. The gene discussed is MYC; the disease is breast carcinoma.